Abstract:Caroline Tianeze de Castro, 1 Lisiane Freitas Leal, 2 Dandara de Oliveira Ramos, 1 Jerusa da Mota Santana, 3 Rosa Cândida Cordeiro, 3, 4 Maria da Conceição Costa Rivemales, 3, 4 Edna Maria de Araújo, 5 Carlos Alberto Lima da Silva, 5 Marcos Pereira, 1 Djanilson Barbosa dos Santos 3– 5 1 Institute of Collective Health, Federal University of Bahia, Salvador, Bahia, Brazil; 2 Centre Hospitalier Universitaire Sainte-Justine Centre de Recherche, Montreal, Quebec, Canada; 3 Center for Health Sciences, Federal University of Recôncavo da Bahia, Santo Antônio de Jesus, Bahia, Brazil; 4 Postgraduation Program in Health for the Black and Indigenous Population, Federal University of Recôncavo da Bahia, Santo Antônio de Jesus, Bahia, Brazil; 5 State University of Feira de Santana, Feira de Santana, Bahia, Brazil Correspondence: Caroline Tianeze de Castro, Institute of Collective Health, Federal University of Bahia, Basílio da Gama Street, no number, Canela Campus, Salvador, Bahia, 40.110-040, Brazil, Email Purpose: This study aimed to evaluate racial disparities in medication use and associated factors among pregnant women receiving prenatal care at Brazilian Unified Health System primary care health units in the northeast region. Patients and Methods: A total of 1058 pregnant women in the NISAMI Cohort were interviewed between June 2012 and February 2014. Medicines used during pregnancy were classified according to the Anatomical Therapeutic Chemical (ATC) classification system and ANVISA pregnancy risk categories. Prevalence ratios (crude and adjusted) and 95% confidence intervals (CIs) were estimated using Poisson regression with robust error variance. All analyses were stratified by race (Asian, black, brown/mixed, Brazilian indigenous, and white). Results: Approximately 84% of the pregnant women used at least one medication, with a lower proportion among white women. The most reported medications were antianemic preparations (71.08%; 95% CI 68.27– 73.72%), analgesics (21.74%; 95% CI 19.36– 24.32%), and drugs for functional gastrointestinal disorders (18.81%; 95% CI 16.57– 21.28%). Approximately 29% of women took potentially risky medications during pregnancy, with a higher prevalence among Asian and white women. Factors associated with medication use during pregnancy include a greater number of prenatal consultations, higher education levels, health problems, and smoking. In addition, maternal age above 25 years, smoking status, and two or more previous pregnancies were associated with potentially risky medication use during pregnancy. Conclusion: A high prevalence of medication use during pregnancy was found; however, this prevalence was lower among white women. Nonetheless, black and brown women used antianemic preparations less frequently. This finding suggests that race is a factor of inequity in prenatal care, demanding public policies to mitigate it. Keywords: drug utilization, racial groups, pregnancy, pharmacoepidemiology, cohort studies Medication use during pregnancy is common in treating acute and chronic conditions through prescription or self-medication. 1 Among the most commonly used medications by pregnant women described in the literature are medicines prescribed to manage pregnancy and nonpregnancy-related conditions, such as ferrous sulfate, folic acid and vitamins, analgesics, antacids, antibiotics, antiemetics, antihistamines, and nonsteroidal anti-inflammatory agents. 2–6 A significant increase in medication consumption by pregnant women has been reported in recent years. 5,7 The prevalence of at least one medication use during pregnancy reaches proportions greater than 90.0% worldwide. 8,9 However, medication use might be related to numerous factors, including healthcare access. 10 Furthermore, medicines such as folic acid, insulin, antacids, ondansetron, ranitidine, methyldopa, hydralazine, enoxaparin sodium, nifedipine, and aspirin are more commonly dispensed to pregnant women than to women of childbearing age. 11 In addition to the characteristics of healthcare systems, medication use patterns may differ by race because of racism. Racism is a structuring system, historically constituted based on the belief of the inferiority of one race or ethnicity to another. It produces practices, beliefs, behaviors, and prejudices that favor avoidable and unfair inequalities between social groups by obstructing access to goods, resources, services, and opportunities. 12,13 Furthermore, institutional racism is a failure by institutions and organizations to provide appropriate and pr -Abstract Truncated-

Accelerating adverse pregnancy outcomes research amidst rising medication use: parallel retrospective cohort analyses for signal prioritization

Clusters, determinants, and short- and long-term effects of coexisting multiple high-risk factors in pregnancy on mothers and their children’s health: study protocol

Development and validation of a machine learning algorithm for predicting the risk of postpartum depression among pregnant women

Detection and evaluation of signals associated with exposure to individual and combination of medications in pregnancy: a signal detection study protocol

Common teratogenic medication exposures-a population-based study of pregnancies in the United States

Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation Strategies

Drug exposure during pregnancy: Current understanding and approaches to measure maternal-fetal drug exposure

Teratogenic Risk Impact and Mitigation (TRIM): Study Protocol for the Development of a Decision Support Tool to Prioritize Medications for Risk Mitigation

Clinical and economic evaluation of a proteomic biomarker preterm birth risk predictor: cost-effectiveness modeling of prenatal interventions applied to predicted higher-risk pregnancies within a large and diverse cohort

Triple challenges – Small sample size in both exposure and control groups to scan rare maternal outcomes in a signal identification approach: A simulation study

Supporting Prospective Pregnancy Trials via Modeling and Simulation: Lessons From the Past and Recommendations for the Future

Impact of early preeclampsia prediction on medication adherence and behavior change: a survey of pregnant and recently-delivered individuals

Risk Identification in Perinatal Health Care Settings via Technology-Based Recruitment Methods: Comparative Study

The Methodological Quality of Observational Studies Examining the Risk of Pregnancy Drug Use on Congenital Malformations Needs Substantial Improvement: A Cross-Sectional Survey

Time-dependent Propensity Score for Assessing the Effect of Vaccine Exposure on Pregnancy Outcomes Through Pregnancy Exposure Cohort Studies.

Protocol of a prospective and multicentre China Teratology Birth Cohort (CTBC): association of maternal drug exposure during pregnancy with adverse pregnancy outcomes

Treatments for pregestational chronic conditions during pregnancy: emulating a target trial with a treatment decision design

The Impact of Confounder Selection in Propensity Scores for Rare Events Data - with Applications to Birth Defects

Racial Disparities in Medication Use During Pregnancy: Results from the NISAMI Cohort

Optimizing Pharmacology Studies in Pregnant and Lactating Women Using Lessons From HIV: A Consensus Statement

A contemporary review of machine learning to predict adverse pregnancy outcomes from pharmaceuticals, including DDIs